Kathleen Schneekloth, MD
Radiation Oncology · Sioux Falls, SDNPI 1891757290
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by AstraZeneca at 55.4% of the total. Reporting peaked in 2022 at $2,045 and has fallen 92.2% since, to $160 in 2025.
Across 35 payments — averaging $108.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Palette Life Sciences, Inc.$1K
- Johnson & Johnson$105
- Takeda Pharmaceuticals U.S.A., Inc.$60
- Novartis$40
- Beigene USA, Inc.$37
- plus $233 from 12 others
What the payments were for
- Consulting fees$2,03053%
- Travel & lodging$90424%
- Food & beverage$87723%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 4 | $2,110 |
| Palette Life Sciences, Inc. | 4 | $1,225 |
| Johnson & Johnson | 6 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Novartis | 2 | $40 |
| Beigene USA, Inc. | 2 | $37 |
| Eisai Inc. | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Iovance Biotherapeutics, Inc. | 1 | $24 |
| Taiho Oncology, Inc. | 1 | $18 |
| Sanofi | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| Amgen | 1 | $15 |
| Merck | 1 | $15 |
| Myriad Genetic Laboratories, Inc. | 1 | $15 |
| AVEO Pharmaceuticals, Inc. | 1 | $15 |
| Pharmacosmos Therapeutics Inc. | 1 | $14 |
| Rigel Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$2,030
How this compares
Too few radiation oncology providers in South Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Sioux Falls
- Kyle ArnesonSioux Falls$2K
- Ryan NowakSioux Falls$191
- Charles MurphySioux Falls$164
- Joel GrowSioux Falls$99
- Michele LohrSioux Falls$25
- Na SmithSioux Falls$0
- Collin NoldnerSioux Falls$0
- Steven McGrawSioux Falls$0
- Daniel PetereitRapid City$6K
- Jeffrey BrindleWatertown$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.